BLOG

Field representatives often (mistakenly) perceive that virtual speaker programs are not worth the effort. We hear some clients saying that their representatives resist virtual programs because they claim they’re too difficult to set up. They take too much time. Technology is a hurdle. These perceptions have become one of the

Vision2Voice (V2V) is proud to participate in Patient Advocacy Organization (PAO) Action Week™ from June 9–13. Founded by Astellas Pharma Inc., PAO Action Week celebrates the vital work of Patient Advocacy Organizations—more than 1,200 U.S. nonprofits that amplify the voices, needs, and rights of patients, particularly those living with serious

National broadcasts have an excellent impact on investment in education, as measured by both market share change and return on investment, but there are still many myths to overcome.  Let’s shed light on the most common myths we encounter and share what the reality looks like for companies that have successfully

Source: PharmaVoice The tariff war has prompted new calls to reshore manufacturing. Several large organizations have already made the leap as BioPharma leverages technological advances such as continuous manufacturing, AI-enabled processes, robotics and automation have brought labor costs down, and regulators are offering more support. READ FULL ARTICLE Source: Reuters

Pharmaceutical advisory boards are vital opportunities to gather expert input, but their success depends greatly on planning and facilitation. Too often, companies treat key opinion leaders (KOLs) like celebrities rather than partners, stifling honest feedback and diverse perspectives. The real value emerges when facilitators create an environment where all participants

When an existing client or new client calls me about key opinion leader (KOL) or Key External Expert (KEE) Identification, they have a purpose in mind for conducting this research. These are some of my favorite client discussions because they are usually with strategic individuals looking to solve internal challenges.

Top-tier Key Opinion Leaders (KOLs)/ Key External Experts (KEEs) and Digital Opinion Leaders (DOLs) are among the most influential voices in the pharmaceutical industry. Their expertise is in high demand. Not just from BioPharma companies, but from financial firms and other institutions eager to leverage their insights. These respected leaders

We’ve been hearing a lot about the evolution of Digital Opinion Leaders (DOLs), so we’ve curated some articles on this topic and hope you find them informative:  Source: The Wall Street Journal Explore the emergence of DOLs in the life sciences industry. This article discusses how pharmaceutical and medical device